Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Ischemic Attack, Transient

3,4-methylenedioxyamphetamine has been researched along with Ischemic Attack, Transient in 1 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Roh, JK1
Hong, SB1
Yoon, BW1
Kim, MS1
Myung, H1

Other Studies

1 other study available for 3,4-methylenedioxyamphetamine and Ischemic Attack, Transient

ArticleYear
The effect of hyperglycemia on lipid peroxidation in the global cerebral ischemia of the rat.
    Journal of Korean medical science, 1992, Volume: 7, Issue:1

    Topics: 3,4-Methylenedioxyamphetamine; Adenosine Triphosphate; Animals; Hyperglycemia; Ischemic Attack, Tran

1992